Novel Heteroaryl Compounds as CD73 Inhibitors for Treating Cancer

被引：1

作者：

Sabnis, Ram W. ^{[1
]}

机构：

[1] Smith Gambrell & Russell LLP, Atlanta, GA 30309 USA

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2024年 / 15卷 / 06期

关键词：

D O I：

10.1021/acsmedchemlett.4c00230

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Provided herein are novel heteroaryl compounds as CD73 inhibitors, pharmaceutical compositions, use of such compounds in treating cancer, and processes for preparing such compounds.

引用

页码：775 / 776

页数：2

共 6 条

[1] Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
Bisht, Kamlesh
Fukao, Taro
Chiron, Marielle
Richardson, Paul
Atanackovic, Djordje
Chini, Eduardo
Chng, Wee Joo
Van De Velde, Helgi
Malavasi, Fabio
[J]. CANCER MEDICINE, 2023, 12 (20): : 20332 - 20352
[2] Small molecular CD73 inhibitors: Recent progress and future perspectives
Ge, Gong-hui
Wang, Qiu-yin
Zhang, Zhen-hao
Zhang, Xu
Guo, Shuai
Zhang, Ting-jian
Meng, Fan-hao
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 264
[3] CD73 in glioblastoma: Where are we now and what are the future directions?
Gelsleichter, Nicolly Espindola
Azambuja, Juliana Hofstatter
Rubenich, Dominique Santos
Braganhol, Elizandra
[J]. IMMUNOLOGY LETTERS, 2023, 256 : 20 - 27
[4] Metabolic interplay: tumor macrophages and regulatory T cells
Vilbois, Stefania
Xu, Yingxi
Ho, Ping-Chih
[J]. TRENDS IN CANCER, 2024, 10 (03) : 242 - 255
[5] Chimeric antigen receptor natural killer cells: a promising antitumor immunotherapy
Wang, Yan
Jin, Shengjie
Zhuang, Qiqi
Liu, Na
Chen, Ruyi
Adam, Sofia Abdulkadir
Jin, Jie
Sun, Jie
[J]. MEDCOMM, 2023, 4 (06):
[6] Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds
Zhang, Mingxue
Dai, Xiaoqin
Xiang, Yu
Xie, Linshen
Sun, Minghan
Shi, Jianyou
[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 258

← 1 →